ABOS Stock: Acumen Pharmaceuticals, Inc. Stock Price, Analysis & Insights
Get live abos stock price $1.88, comprehensive Acumen Pharmaceuticals, Inc. stock analysis, charts, news, and expert forecast. Real-time abos stock data and investment insights.
Loading chart...
Company Overview
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Company Information
- CEO
- Daniel J. O'Connell
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 61
Contact Information
- Website
- https://acumenpharm.com
- Address
- 427 Park Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.24) may provide portfolio stability
Business Model & Strategy
Acumen Pharmaceuticals, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Daniel J. O'Connell, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Acumen Pharmaceuticals, Inc. competes in the Biotechnology within the broader Healthcare. With 113.9 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Acumen Pharmaceuticals, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Acumen Pharmaceuticals, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Acumen Pharmaceuticals, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Acumen Pharmaceuticals, Inc.
- ⚠Investors should consider how Acumen Pharmaceuticals, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
113.88M
P/E Ratio
-0.83
Beta
0.24
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 113.88M market capitalization
- Trading Volume: 282.77K shares traded today
- Price Range: 52-week range of $0.85 - $3.36
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. (ABOS) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 113.88M, the company represents a significant player in its market. The stock is currently trading at $1.88 with a negativedaily change of 0.79%.
The company's 61 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.83, beta of 0.24, and 52-week price range from $0.85 to $3.36when evaluating investment opportunities.
Why Invest in Acumen Pharmaceuticals, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Daniel J. O'Connell
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.